Birdwatch Note
2023-04-03 16:24:30 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The FDA said in a statement that an “available treatment for COVID-19 does not preclude the FDA from authorizing a vaccine to prevent COVID-19.” Remdesivir and convalescent plasma were both approved for treatment before any vaccines were given emergency use authorization. https://apnews.com/article/fact-check-covid-vaccines-emergency-use-873264912929
Written by 72A59FB5955991E68C6349DA62C35A734500BE2AEFDA828D7BB704AB0E76465C
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1642545321216466944
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1642926055668486144
- noteId - 1642926055668486144
- participantId -
- noteAuthorParticipantId - 72A59FB5955991E68C6349DA62C35A734500BE2AEFDA828D7BB704AB0E76465C Participant Details
- createdAtMillis - 1680539070419
- tweetId - 1642545321216466944
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The FDA said in a statement that an “available treatment for COVID-19 does not preclude the FDA from authorizing a vaccine to prevent COVID-19.” Remdesivir and convalescent plasma were both approved for treatment before any vaccines were given emergency use authorization. https://apnews.com/article/fact-check-covid-vaccines-emergency-use-873264912929
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-04-03 16:24:30 UTC (1680539070419) |
1969-12-31 23:59:59 UTC (-1) |
2023-04-04 02:08:15 UTC (1680574095414) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-04-05 07:38:39 -0500 | Rating Details | |
2023-04-04 20:58:10 -0500 | Rating Details | |
2023-04-04 11:43:39 -0500 | Rating Details | |
2023-04-03 20:53:57 -0500 | Rating Details | |
2023-04-03 19:38:23 -0500 | Rating Details | |
2023-04-03 19:37:01 -0500 | Rating Details | |
2023-04-03 19:32:37 -0500 | Rating Details | |
2023-04-03 18:57:18 -0500 | Rating Details | |
2023-04-03 18:44:50 -0500 | Rating Details | |
2023-04-03 18:26:48 -0500 | Rating Details | |
2023-04-03 17:47:39 -0500 | Rating Details | |
2023-04-03 17:15:02 -0500 | Rating Details | |
2023-04-03 16:40:51 -0500 | Rating Details | |
2023-04-03 16:34:08 -0500 | Rating Details | |
2023-04-03 16:33:10 -0500 | Rating Details | |
2023-04-03 16:22:37 -0500 | Rating Details | |
2023-04-03 16:16:41 -0500 | Rating Details | |
2023-04-03 16:11:55 -0500 | Rating Details | |
2023-04-03 16:06:08 -0500 | Rating Details | |
2023-04-03 16:03:10 -0500 | Rating Details | |
2023-04-03 16:02:48 -0500 | Rating Details | |
2023-04-03 15:57:48 -0500 | Rating Details | |
2023-04-03 15:55:08 -0500 | Rating Details | |
2023-04-03 15:50:14 -0500 | Rating Details | |
2023-04-03 15:44:34 -0500 | Rating Details | |
2023-04-03 15:32:34 -0500 | Rating Details | |
2023-04-03 15:28:53 -0500 | Rating Details | |
2023-04-03 15:27:15 -0500 | Rating Details | |
2023-04-03 15:26:35 -0500 | Rating Details | |
2023-04-03 15:24:33 -0500 | Rating Details | |
2023-04-03 15:23:43 -0500 | Rating Details | |
2023-04-03 15:21:42 -0500 | Rating Details | |
2023-04-03 15:18:42 -0500 | Rating Details | |
2023-04-03 15:11:19 -0500 | Rating Details | |
2023-04-03 15:03:12 -0500 | Rating Details | |
2023-04-03 14:57:23 -0500 | Rating Details | |
2023-04-03 14:55:22 -0500 | Rating Details | |
2023-04-03 14:52:43 -0500 | Rating Details | |
2023-04-03 14:24:25 -0500 | Rating Details | |
2023-04-03 14:22:09 -0500 | Rating Details | |
2023-04-03 14:20:42 -0500 | Rating Details | |
2023-04-03 14:14:21 -0500 | Rating Details | |
2023-04-03 14:13:55 -0500 | Rating Details | |
2023-04-03 14:10:47 -0500 | Rating Details | |
2023-04-03 14:10:16 -0500 | Rating Details | |
2023-04-03 14:02:00 -0500 | Rating Details | |
2023-04-03 14:01:19 -0500 | Rating Details | |
2023-04-03 14:00:35 -0500 | Rating Details | |
2023-04-03 13:56:16 -0500 | Rating Details | |
2023-04-03 13:47:46 -0500 | Rating Details | |
2023-04-03 13:17:33 -0500 | Rating Details | |
2023-04-03 13:04:54 -0500 | Rating Details | |
2023-04-03 12:37:33 -0500 | Rating Details | |
2023-04-03 12:33:17 -0500 | Rating Details | |
2023-04-03 11:55:22 -0500 | Rating Details | |
2023-04-03 11:53:34 -0500 | Rating Details | |
2023-04-03 11:41:14 -0500 | Rating Details | |
2023-04-03 11:37:07 -0500 | Rating Details | |
2023-04-03 11:36:12 -0500 | Rating Details | |
2023-04-03 11:33:13 -0500 | Rating Details | |
2023-04-10 11:36:05 -0500 | Rating Details | |
2023-04-09 17:04:37 -0500 | Rating Details | |
2023-04-14 08:33:20 -0500 | Rating Details | |
2023-04-17 20:16:33 -0500 | Rating Details | |
2023-04-03 14:01:19 -0500 | Rating Details | |
2023-04-03 14:20:42 -0500 | Rating Details | |
2023-04-03 16:03:10 -0500 | Rating Details | |
2023-04-03 14:55:22 -0500 | Rating Details | |
2023-04-03 15:23:43 -0500 | Rating Details | |
2023-04-03 18:44:50 -0500 | Rating Details | |
2023-04-03 11:33:13 -0500 | Rating Details | |
2023-04-03 19:38:23 -0500 | Rating Details | |
2023-04-03 19:37:01 -0500 | Rating Details | |
2023-04-14 08:33:20 -0500 | Rating Details | |
2023-04-03 16:16:41 -0500 | Rating Details | |
2023-04-03 15:27:15 -0500 | Rating Details | |
2023-04-03 14:10:16 -0500 | Rating Details | |
2023-04-03 15:32:34 -0500 | Rating Details | |
2023-04-04 20:58:10 -0500 | Rating Details | |
2023-04-03 16:02:48 -0500 | Rating Details | |
2023-04-03 11:53:34 -0500 | Rating Details | |
2023-04-03 13:17:33 -0500 | Rating Details | |
2023-04-03 12:37:33 -0500 | Rating Details | |
2023-04-03 20:53:57 -0500 | Rating Details | |
2023-04-03 15:03:12 -0500 | Rating Details | |
2023-04-03 16:34:08 -0500 | Rating Details | |
2023-04-03 15:24:33 -0500 | Rating Details | |
2023-04-03 15:21:42 -0500 | Rating Details | |
2023-04-03 14:24:25 -0500 | Rating Details | |
2023-04-17 20:16:33 -0500 | Rating Details | |
2023-04-03 14:14:21 -0500 | Rating Details | |
2023-04-03 14:57:23 -0500 | Rating Details | |
2023-04-03 11:55:22 -0500 | Rating Details | |
2023-04-03 17:15:02 -0500 | Rating Details | |
2023-04-03 14:22:09 -0500 | Rating Details | |
2023-04-03 15:57:48 -0500 | Rating Details | |
2023-04-03 17:47:39 -0500 | Rating Details | |
2023-04-09 17:04:37 -0500 | Rating Details | |
2023-04-03 13:56:16 -0500 | Rating Details | |
2023-04-03 19:32:37 -0500 | Rating Details | |
2023-04-03 15:26:35 -0500 | Rating Details | |
2023-04-03 14:00:35 -0500 | Rating Details | |
2023-04-03 11:37:07 -0500 | Rating Details | |
2023-04-03 16:11:55 -0500 | Rating Details | |
2023-04-03 16:33:10 -0500 | Rating Details | |
2023-04-03 13:04:54 -0500 | Rating Details | |
2023-04-03 18:57:18 -0500 | Rating Details | |
2023-04-03 15:55:08 -0500 | Rating Details | |
2023-04-03 14:10:47 -0500 | Rating Details | |
2023-04-03 11:41:14 -0500 | Rating Details | |
2023-04-03 16:06:08 -0500 | Rating Details | |
2023-04-03 15:18:42 -0500 | Rating Details | |
2023-04-03 14:02:00 -0500 | Rating Details | |
2023-04-03 16:40:51 -0500 | Rating Details | |
2023-04-05 07:38:39 -0500 | Rating Details | |
2023-04-03 15:28:53 -0500 | Rating Details | |
2023-04-03 15:44:34 -0500 | Rating Details | |
2023-04-03 11:36:12 -0500 | Rating Details | |
2023-04-03 12:33:17 -0500 | Rating Details | |
2023-04-10 11:36:05 -0500 | Rating Details | |
2023-04-03 18:26:48 -0500 | Rating Details | |
2023-04-03 14:13:55 -0500 | Rating Details | |
2023-04-03 14:52:43 -0500 | Rating Details | |
2023-04-03 15:50:14 -0500 | Rating Details | |
2023-04-04 11:43:39 -0500 | Rating Details | |
2023-04-03 13:47:46 -0500 | Rating Details | |
2023-04-03 15:11:19 -0500 | Rating Details |